Our newest survey highlights what many already know: managing SLD isn&rsquo;t just about liver health. Barriers like transportation, finances, isolation, and mental health challenges play a big role in how people experience their condition. Join us for an honest, community conversation about these realities, and hear about programs and resources designed to help you take care of both your health and your well-being.<br />
<br />
<strong>Zoom:</strong> <a href="https://us02web.zoom.us/webinar/register/WN_bPc7LXWuQcuhltX1HFZ1zw">htt…;

&quot;Sober&quot; can mean more than life without alcohol&mdash;it can also mean approaching life with clarity, balance, and thoughtful awareness. This conversation explores the many meanings of sobriety&mdash;clarity, calm, and conscious living&mdash;and how those qualities help us navigate a world that feels increasingly loud and unsettled. Together, we&rsquo;ll talk about what&rsquo;s within our control, what&rsquo;s not, and how to stay steady, compassionate, and connected without diving into divisive topics&mdash;focusing instead on how the world around us shapes our inner resilience.<br />
<br />
<strong>Zoom: </strong><a href="https://us02web.zoom.us/meeting/register/s49_sh31TWOuhSOUQR7Iug">https:…;

This program is designed to explore the recent FDA announcement and <em>HEPATOLOGY</em>&nbsp;publication regarding the role of non-invasive tests (NITs) in MASH clinical trials. The session will review the regulatory perspectives, scientific evidence, and clinical implications of these developments. It will also provide a forum for open dialogue and audience engagement, highlighting both opportunities and challenges for integrating NITs into practice and research. Attendees will leave with a clearer understanding of how these updates may shape the future landscape of hepatology and drug development.

Stigma surrounding liver disease impacts patient outcomes, mental health, and access to care. Presenters explore the roots of stigma, with a focus on how misconceptions about liver disease affect care delivery and perpetuate health inequities. Special attention is given to the unique challenges faced by LGBTQ+ patients, who often encounter additional layers of bias and discrimination. The goal of this session is to empower health care clinicians, advocates, and stakeholders to foster equity and empathy in liver care for all communities by recognizing the impact of stigma on patient outcomes; developing inclusive practices for stigma-free care; and advocating for systemic change.

This joint AASLD and the Taiwan Association for the Study of the Liver (TASL) session aims to: (1) continue the collaborative relationship between TASL and AASLD; (2) share experiences and contributions to HCC surveillance in Taiwan with AASLD members; (3) facilitate young investigators' communication with AASLD members to foster future collaboration; and (4) encourage TASL members to attend The Liver Meeting to learn from and connect with scholars from around the world.

Join members of the Liver Leaders Council in the Patient Lounge for a meet and greet to learn more about Clinical Trials.

In an ever-evolving digital landscape, staying connected and innovative is essential for advancing hepatology. This interactive session explores how social media and emerging technologies can shape the field, enhance professional collaboration, and improve patient care. The session begins with an overview of AASLD's current digital initiatives including highlights of the Tech and Communication Committees and the emerging Informatics Interest Group. Presenters then take a deep dive into the shifting social media landscape in hepatology, including the migration from Twitter (X) to newer platforms like Bluesky and the growing impact of short video platforms. Discover strategies to maintain a vibrant social media community in hepatology while effectively using these new tools for networking, advocacy, and patient education. Speakers also explore cutting-edge technologies revolutionizing hepatology. From artificial intelligence (AI)-driven diagnostics to smartphone apps and advanced electronic health records (EHR) applications, this presentation highlights the transformative potential of tech innovations in daily clinical practice. The session concludes with an open floor discussion, inviting attendees to share their insights, challenges, and ideas on leveraging digital tools like social media, AI, and other technology applications to better serve AASLD members and communities. 

Come discuss the science behind the October special issue of Hepatology on cholestatic liver disease with Hepatology Associate Editor Dr. Aliya Gulamhusein. Read the issue here:&nbsp;<a href="https://journals.lww.com/hep/toc/2025/10000">https://journals.lww.com/h… />
&nbsp;<br />
12:45-12:55 PM- Presentation<br />
12:55 PM-1:15 PM- Audience Q&amp;A and Discussion<br />
&nbsp;

<p>Late Breaking! Join AASLD scientific leaders to discuss the latest AASLD MASLD Practice Guidance update. &nbsp;What has changed? &nbsp;</p>

<p>Presenters: Meena Bansal, MD, FAASLD and the MASLD Guidance Writing Group</p>